Board Meeting Details

A meeting of the Board of Directors is scheduled to be held on Wednesday, August 05, 2026. The primary agenda includes approving and taking on record the un-audited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026 (Q1 FY 2026-27), among other routine matters.

Trading Window Closure

Pursuant to the Company's Code of Conduct for Prevention of Insider Trading read with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company has been closed from Wednesday, July 01, 2026 to Friday, August 07, 2026 (both days inclusive). The trading window will reopen on Saturday, August 08, 2026.

Earnings Conference Call Details

The Company will organize an Earnings Conference Call for Analysts and Investors on Thursday, August 06, 2026 at 10:00 hrs IST. The call will be conducted over Zoom.

Registration and Access Details

  • Registration Link: Provided in the document (clickable link)
  • Participants are requested to join 10 minutes before the scheduled start time

Recording Availability

  • Audio recording will be made available before the next trading day or within 24 hours from the end of the call, whichever is earlier
  • Video recording will be made available within 48 hours from the end of the call
  • Recordings accessible on Company website: Biocon > Investors > Financial Information > Earnings Call Recordings

Transcript Availability

Conference call transcript will be made available within 5 working days of the conclusion of the call on the Company website: Biocon > Investors > Financial Information > Earnings Call Transcripts

Additional Information

The information will also be available on the Company website at www.biocon.com.

Safe Harbor Statement

The document includes a standard safe harbor statement noting that certain statements made in the conference call may be forward-looking and subject to various risks and uncertainties including general economic conditions, currency fluctuations, regulatory changes, competition, and political conditions. The company assumes no obligation to update any forward-looking statements.